Home / Market News / $CAH
fiscal.ai Corporate Catalyst Impact 55/100 ● positive

RBC Raises Price Target on Cardinal Health to $295 From $276

Nov 6, 2026, 4:04 PM UTC · Primary ticker $CAH

RBC Capital Markets has increased its price target for Cardinal Health (CAH) from $276 to $295, while maintaining an Outperform rating. This adjustment reflects RBC's updated valuation following the company's recent financial reporting, suggesting a positive outlook from the analyst firm.

RBC Capital Markets analyst Ryan Halsted raised the price target for Cardinal Health (CAH) to $295 from $276, while reiterating an Outperform rating. This move signals increased confidence from RBC in Cardinal Health's future performance, likely stemming from a positive interpretation of the company's recent financial results. For traders, this could provide a short-term positive sentiment boost for CAH stock, as analyst upgrades often attract investor attention. The long-term implications depend on whether the company's fundamentals continue to support this higher valuation. A key opportunity for traders lies in potential upward momentum if other analysts follow suit or if the market reacts favorably to this revised outlook.

$CAH positive Price target increase by RBC
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.